S 765 · 118th Congress 2023–2025, ended

Reducing Hereditary Cancer Act of 2023

Latest action · Mar 9, 2023 Read twice and referred to the Committee on Finance.

Progress

Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.

  1. IntroducedMar 9, 2023
  2. Passed SenateNot reached
  3. Passed HouseNot reached
  4. To the PresidentNot reached
  5. Became lawNot reached

Summary

Reducing Hereditary Cancer Act of 2023

This bill provides for Medicare coverage of germline mutation testing for individuals with a personal or family history of a hereditary cancer gene mutation or suspected history of hereditary cancer, as well as for associated coverage of risk-reducing surgeries and screenings.

Cosponsors 2

Members who signed on, in the order they did. Signatures ran from Mar 9, 2023 to Nov 12, 2024; 1 is an original cosponsor, there from the day it was introduced.

SeatCosponsorSigned on
D-MDBenjamin L. CardinOriginalMar 9, 2023
D-MIGary C. PetersNov 12, 2024

Committees 1

Where it was sent and what each committee and subcommittee did with it, in order.

ChamberCommitteeWhat it did
SenateFinance Committee
Referred Mar 9, 2023

Actions 2

Everything that happened, newest first.

  1. Mar 9, 2023Introduced in Senate
  2. Mar 9, 2023Read twice and referred to the Committee on Finance.

Related bills 1

Companion bills and other measures the record links to this one.

BillTitleRelationshipLatest action
HR 1526Reducing Hereditary Cancer ActRelated billDec 17, 2024

Titles 2

Every title it has carried, official and short, at each stage.

Official Title as Introduced
A bill to amend title XVIII of the Social Security Act to provide hereditary cancer genetic testing for individuals with a history of a hereditary cancer gene mutation in a blood relative or a personal or ancestral history suspicious for hereditary cancer, and to provide coverage of certain cancer screenings or preventive surgeries that would reduce the risk for individuals with a germline (inherited) mutation associated with a high risk of developing a preventable cancer.
Short Title(s) as Introduced
Reducing Hereditary Cancer Act of 2023

Subjects

Assigned by the Library of Congress. Policy area: Health.

Text 1

Each version as it was printed, newest first.

  1. Mar 9, 2023Introduced in Senate

Support LegiList

This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.

Processed by Stripe in a separate window. LegiList never sees card details. Other amounts

Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.